Literature DB >> 18174710

Concepts in the diagnosis of adult growth hormone deficiency.

Beverly M K Biller1.   

Abstract

BACKGROUND: To make a diagnosis of growth hormone deficiency (GHD), individuals with normal GH levels must be distinguished from those who are deficient. This requires an understanding of how GH secretion and other related factors differs between these two groups. The presence of a normal insulin-like growth factor I (IGF-I) level does not necessarily preclude a diagnosis of GHD, whereas a low IGF-I level in a subject with three or four other hormone deficiencies and no conditions that would otherwise lower IGF-I might be sufficient to make the diagnosis. Provocative testing is a clinically relevant method of testing, but not all tests in use have comparable specificity and sensitivity.
CONCLUSIONS: Insulin-induced hypoglycemia is the recommended test to diagnose GHD, but the arginine-GH-releasing hormone test achieves comparable separation between normal and hypopituitary subjects in most groups. Future studies using large surveillance databases may further expand our understanding of concepts underlying GHD and its diagnosis. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18174710     DOI: 10.1159/000110478

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  7 in total

Review 1.  Transitioning of children with GH deficiency to adult dosing: changes in body composition.

Authors:  Vi Thuy Nguyen; Madhusmita Misra
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

2.  Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Curr Top Behav Neurosci       Date:  2014

Review 3.  Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Ann N Y Acad Sci       Date:  2015-03-09       Impact factor: 5.691

4.  Are we studying and treating schizophrenia correctly?

Authors:  Neal R Swerdlow
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

5.  Differential effects of growth hormone versus insulin-like growth factor-I on the mouse plasma proteome.

Authors:  Juan Ding; Edward O List; Brian D Bower; John J Kopchick
Journal:  Endocrinology       Date:  2011-07-26       Impact factor: 4.736

6.  Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy.

Authors:  Savita G Bhakta; Hsun-Hua Chou; Brinda Rana; Jo A Talledo; Bryan Balvaneda; Laura Gaddis; Gregory A Light; Neal R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2016-04-13       Impact factor: 4.530

7.  Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration.

Authors:  Neal R Swerdlow; Juliana E Kotz; Yash B Joshi; Jo Talledo; Joyce Sprock; Juan L Molina; Branko Huisa; Steven F Huege; Jairo Alberto Romero; Michael J Walsh; Lisa Delano-Wood; Gregory A Light
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.